The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that ...

BioMarin has followed through on its shift to external innovation, inking a deal to buy Inozyme for $270 million to add a ...

After a patient died following a high dose of Neurogene’s Rett syndrome gene therapy candidate, the biotech is sharing ...

Rocket Pharmaceuticals has shared early data from three patients that tie its gene therapy for an inherited heart disease to ...

After more than two decades as a Big Pharma cancer leader, Nicholas Botwood is swinging into the biotech world as the new ...

After publishing early clinical results of its ultrasound-activated brain tumor therapy this year, Alpheus Medical has raised ...

Eli Lilly is further expanding its RNA medicine strategy by tapping South Korea’s Rznomics for a $1.3 billion biobucks deal ...